Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as myostatin). Trevogrumab is used in research on muscle wasting conditions, including disuse atrophy, chronic diseases, and changes in food and nutrient intake[1][2][3].
Molecular Weight:
(144.04 kDa)
Purity:
99.77
CAS Number:
[1429201-24-0]
Target:
TGF-beta/Smad
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted